Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
University of British Columbia
$58,333.00
Identification and Therapeutic Targeting of Dysfunctional Immune Networks in Human Inflammatory Diseases
EF 2010-11
Résumé
Inflammation is a normal transient biological response initiated by the innate immune system to help contain and control infections. Despite its essential role in human survival, an overly robust or inappropriate immune response paradoxically damages tissue and leads to the development of inflammatory disease. Inflammatory bowel disease (IBD) and cystic fibrosis (CF), both of which are extremely common in Canada, are examples of human diseases driven by chronic inflammation caused by dysfunctional innate immune responses to bacteria. Recently, a new class of anti-infective drugs termed innate defense regulators (IDRs) have entered clinical trials. IDRs are significantly different from conventional antibiotics; rather than attacking the infection directly, IDRs work by enhancing the beneficial components of the immune system while simultaneously suppressing the harmful components which cause inflammation. The overall aim of this research study is to gather information that will aid in the development of new therapeutics for CF, IBD, and other human diseases caused by dysfunctional innate immune responses and chronic inflammation. Furthermore, this research will examine if IDRs show efficacy in CF and IBD disease models, given their ability to limit harmful inflammation in the face of bacterial infection. Ultimately, the information obtained during this research study will help provide a better understanding on how of innate immunity and inflammation cause illness in order to aid in the development of new medications or therapeutic approaches for these devastating diseases.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
229690
Name
Mayer Matthew L
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Identification and Therapeutic Targeting of Dysfunctional Immune Networks in Human Inflammatory Diseases
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$58,333
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Cystic Fibrosis; Immunomodulation; Inflammation; Inflammatory Bowel Disease; Systems Biology
Abstract
Inflammation is a normal transient biological response initiated by the innate immune system to help contain and control infections. Despite its essential role in human survival, an overly robust or inappropriate immune response paradoxically damages tissue and leads to the development of inflammatory disease. Inflammatory bowel disease (IBD) and cystic fibrosis (CF), both of which are extremely common in Canada, are examples of human diseases driven by chronic inflammation caused by dysfunctional innate immune responses to bacteria. Recently, a new class of anti-infective drugs termed innate defense regulators (IDRs) have entered clinical trials. IDRs are significantly different from conventional antibiotics; rather than attacking the infection directly, IDRs work by enhancing the beneficial components of the immune system while simultaneously suppressing the harmful components which cause inflammation. The overall aim of this research study is to gather information that will aid in the development of new therapeutics for CF, IBD, and other human diseases caused by dysfunctional innate immune responses and chronic inflammation. Furthermore, this research will examine if IDRs show efficacy in CF and IBD disease models, given their ability to limit harmful inflammation in the face of bacterial infection. Ultimately, the information obtained during this research study will help provide a better understanding on how of innate immunity and inflammation cause illness in order to aid in the development of new medications or therapeutic approaches for these devastating diseases.
Competitiondate
201010
Approvedterm2
1 yr 8 mths
Pinamesdelim
Mayer, Matthew L
Approvedterm
1 an 8 mois
Cihrcontribution2
~ $58,333~ $0~